Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion

Raymund Buhmann,Belinda Pinto Simões,Michael Stanglmaier,Ting Yang,Faltin M,Dagmar Bund,Horst Lindhofer,Kolb Hj

Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion

2009

Raymund Buhmann
Belinda Pinto Simões
Michael Stanglmaier
Ting Yang
Faltin M
Dagmar Bund
Horst Lindhofer
Kolb Hj

Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 × anti-CD20 antibody and donor lymphocyte infusion

Keywords:

Muromonab-CD3
Immunology
Antibody
Chronic lymphocytic leukemia
Immunotherapy
CD20
Donor lymphocyte infusion
Medicine
B cell
Monoclonal antibody
Alemtuzumab
Trifunctional antibody
Rituximab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations